CME: Bipolar and mood disorder: Therapeutic updates and best practices
Activity Description / Statement of Need:
In this online CME self-learning activity:
Bipolar disorder is a mood disorder characterized by episodes of mania, hypomania, and depression. It affects 3-4% of the U.S. population, represents a substantial societal and economic burden in the United States, is also found to be strongly associated with other major public health concerns like diabetes and cardiovascular disease as well as suicide.
The literature demonstrates that medication nonadherence is a major issue among patients with bipolar disorder. Nonadherence affects approximately 60% of patients and can result in hospitalization, poor effectiveness, increased relapses, and increased risk of morbidity. Other factors, such as patient perceptions, illness severity, and the relationship between the physician and patient, come into play and should be taken into account to optimize adherence.
Target Audience:
Healthcare professionals specializing in: family medicine, internal medicine, mental health, neurology and psychiatry, or those who otherwise commonly care for patients with bipolar or related psychiatric diseases.
This program is supported by an educational grant from Alkermes.
Learners may participate in this activity free of charge.
Release Date: September 11, 2020 -- Expiration Date: September 11, 2022
Faculty: Rimal Bera, MD
Agenda
|
Introduction, disclosures |
|
Bipolar disorder’s epidemiology, neuropathophysiology, presentation, comorbidities, and psychosocial impact:
o Diagnostic criteria
|
|
Treatment with an emphasis on bipolar disorder I
o Prescription medications o Acute treatment of mania o Mixed episodes o Maintenance treatment o Treatment follow-up and assessment of outcomes
o Best practice: Putting it all together o Patient case(s) |
|
Summary, conclusions, and best practice recap |
Learning Objectives
By the end of the session the participant will be able to:
- Identify current and emerging treatment modalities for the management of bipolar disorder and apply them to patient cases using evidence-based medicine.
- Evaluate a specific patient during the maintenance phase of therapy and suggest modifications for improvement, taking into account: Efficacy; changes in symptoms; adverse effects of therapy; and impact on quality of life.
- Describe the challenges associated with treating patients with bipolar disorder, including medication adherence and adverse effects, such as weight gain.
- Recall the pathophysiology of bipolar disorder as it relates to the mechanisms of action of available and emerging pharmacotherapies.
Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through ScientiaCME. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: ScientiaCME designates this educational activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™ toward the AMA Physician's Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Physicians: For applicable courses, to attain maintenance of certification (MOC) credit, you must enter your board certification ID # and birth date correctly. It is the learner's responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive MOC credit for this activity. Please note: not all activities on this site provide MOC credit. If this activity does not specify that it provides MOC credit in the "Accreditation" section on this page, then it does NOT provide MOC credit.
Pharmacists
ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for 1.00 hours (0.1 CEUs) of continuing education. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. ACPE # 0574-0000-20-041-H01-P. ACPE Accreditation effective 9/11/2020, expires 9/11/2022. This is a Application (A)-type activity.
Nurse Practitioners (NPs): The American Academy of Nurse Practitioners accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. ScientiaCME will provide NPs who successfully complete each activity with a certificate of participation indicating that the activity was designated for AMA PRA Category 1 Credit(s)™.
Physician Assistants: The American Academy of Physician Assistants accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
Faculty Disclosure and Resolution of COI
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Remal Bera, MD, Clinical Professor, Department of Psychiatry & Human Behavior, University of California, Irvine, has no relevant conflicts of interest to disclose.
Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP, CEO of ScientiaCME, has no relevant conflicts of interest to disclose.
Commercial Support Disclosure: This program is supported by an educational grant from Alkermes.
Instructions
- Read the learning objectives above
- Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowedge gained by participating in this CME activity.
- View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
- Take the post-test
- Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.
System Requirements
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.
Additional Courses That Are Related To This Activity
Improving the treatment and management of schizophrenia: An overview of current and novel approaches
Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents: Updates from APA 2019
Attention Deficit Hyperactivity Disorder (ADHD) in Adults: Updates from APA 2019